India Registers 14,313 New COVID-19 Cases

In India, in the last 24 hours, 14,313 fresh COVID-19 cases and 549 deaths have been registered, said the Union Health Ministry.

The new fatalities increased the death toll to 4,57,740.

Fluvoxamine: An OCD Drug can Prevent Covid-19 Patients from Hospitalization
Fluvoxamine has been proven among one such drug that could be used to treat COVID-19. Dozens of COVID patients showed no clinical deterioration in their symptoms when treated with a drug, fluvoxamine.

The recovery of 13,543 patients in the last 24 hours has increased the cumulative tally to 3,36,41,175.

Consequently, India's recovery rate stands at 98.19 per cent.

Meanwhile, the weekly positivity rate is 1.18 per cent, which is less than 2 per cent for the last 36 days.

Green Fungus or Aspergillosis and COVID-19 Infection
Green fungus or Aspergillosis is caused by a common mold, which exists both indoors and outdoors. Every day, people inhale Aspergillus spores, but it isn't harmful. However, it affects people who have a weak immune system. If the infection is left untreated, it can cause pneumonia.

As many as 1,61,555 active cases at present constitute 0.47 per cent of the country's total positive cases, which is the lowest since March 2020.

Sustained and collaborative efforts by the Centre and the states/UTs continue the trend of less than 50,000 daily new cases that are being reported for 125 consecutive days now.

Test your Knowledge on Coronavirus (COVID-19)
Coronavirus is a large positive-strand RNA virus that is surrounded by a protein envelope. The virus obtains its name from the S protein spikes on its surface, which resemble a crown. The overall pattern of increasing coronavirus cases is shown to spike up with the “second wave” of COVID-19.

With spiking effects of the second wave of coronavirus, the best way to keep it at bay is to follow COVID-appropriate safety practices like wearing a mask, regularly cleaning your hands, and coughing into a bent elbow or tissue along with physical distancing (6 feet about 2 arm's length), that may help evade the severity of COVID-19 infection.

The daily positivity rate was reported to be 1.22 per cent. It rate has remained below 2 per cent for the last 26 days.

General Practice Continues to Play a Central Role in the Fight Against COVID-19
The Ministry for Health in Australia announced that additional measures to support general practitioners (GP) to care for COVID-19 patients in the community.

The last 24 hours saw a total of 11,76,850 tests being conducted. India has so far conducted over 60.70 crore cumulative tests.

This has been achieved through 1,05,30,690 sessions.

Source-IANS